Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

hypoglycaemia

- PMLiVE

New ‘NHSX’ unit will lead health service digital transformation

Will bring together public and private sector to accelerate change

- PMLiVE

Big opportunities in big data, but EMA and industry just getting started

250m genomes sequenced, but data trapped in silos

Going digital

Medical devices, Medicine 2.0 and beyond

Lucid Group brings creative and digital magic to the mix with the acquisition of Bluedog

Lucid Group is delighted to announce its first acquisition, welcoming colleagues from creative and digital consultancy Bluedog into its magic kingdom.Over the last twelve years, Lucid Group has become well...

Lucid Group Communications Limited

- PMLiVE

Trulicity’s ascent lifts Lilly

Diabetes treatment leads new product growth

- PMLiVE

Novo Nordisk preps for speedy oral GLP-1 drug filing

Needs to compete with rival's fast-growing Trulicity

- PMLiVE

Pfizer closes on EU approval of lung cancer drug Vizimpro

And AZ claims first with Forxiga in T1 diabetes

- PMLiVE

Nerve centre gives Novartis edge in clinical trials

Algorithms predict potential delays

Sanofi reception

FDA adcomm split on Sanofi’s type 1 diabetes drug

Concerns rose after Zynquista-treated patients showed an eight-fold increase in DKA

- PMLiVE

Merck’s backing of NGM Bio yields NASH drug deal

Drug has potential in diabetes treatment as well

- PMLiVE

D-day: time to make digital deliver

Chris Ross looks at why a platform-based, outcomes-focused approach could be key to demonstrating the value of digital health solutions

- PMLiVE

eConsent: Busting regulatory myths

‘eConsent improves the way consent is obtained, helps keep participants better informed and easily tracks study progress results’

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links